This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
For more than 25 years, life science companies, law firms, and regulatory agencies around the globe have turned to CRA’s life sciences consultants when they need clarity and solutions to the industry’s most complex issues. Clients value our deep industry knowledge, rigorous analytic techniques, and decades of hands-on experience spanning thousands of successful engagements.
The Build Back Better Act, which is under consideration for passage into law includes price controls in Medicare Part B and D and price caps more broadly. In...
Antimicrobial Resistance (AMR) is a serious and increasing threat to global health security and impacts the efficacy of medicines we have come to rely on, made...
Michele Pistollato and Elaine Damato are presenting a poster at on “How should public health recommendations address Lp(a), a causative risk factor for...
Tim Wilsdon is speaking during the session. For more information on this event, click here.
